Department Of Clinical Therapeutics (NYSPI)
Franklin Schneier, MD

Dr. Franklin Schneier is a Special Lecturer at Columbia University College of Physicians and Surgeons and Research Psychiatrist in the Anxiety Disorders Clinic at New York State Psychiatric Institute. Dr. Schneier is a graduate of Yale College and Cornell University Medical College, and he completed his residency in psychiatry at Mt. Sinai Medical Center. He came to the Anxiety Disorders Clinic in 1987 as a research fellow, later serving as associate director of the clinic and currently as a research psychiatrist. He is a member of the Scientific Advisory Board of the Anxiety Disorders Association of America.

Dr. Schneier's research has focused on the diagnosis, treatment, and pathophysiology of social anxiety disorder, other anxiety disorders, and depression. He has been the recipient of Federal funding to conduct clinical trials establishing the efficacy of medications and combined medication-cognitive-behavioral treatments for social anxiety disorder and PTSD. He is also trained in cognitive-behavioral therapy. Dr. Schneier has also been funded by NIMH to use PET and fMRI imaging techniques to study social anxiety disorder and depression. He is author of more than 150 scholarly publications and a book for general audiences, The Hidden Face of Shyness.

Dr. Schneier also maintains a private practice in general psychiatry, including diagnostic assessment and consultations, psychopharmacology and cognitive-behavioral therapy. He combines a focus on evidence-based treatment with recognition of the need for a creative and individualized approach to the unique aspects of each person.

Clinical Studies Managed By This Investigator:
Condition Study Title
Depression [ CLOSED ] Brain Imaging and Medication Study for Depression
Anxiety [ CLOSED ] Treatment for Public Speaking Fears
Anxiety [ CLOSED ] Brief Treatment for People With Social Anxiety
Healthy Volunteers [ CLOSED ] EEG Study for Healthy Volunteers
PTSD [ CLOSED ] A Trial of Brexpiprazole and Sertraline in the Treatment of Post-Traumatic Stress Disorder